Alpha-1-antitrypsin deficiency: what next?

This publication has 22 references indexed in Scilit:

• A Randomized Clinical Trial of α₁-Antitrypsin Augmentation Therapy
  American Journal of Respiratory and Critical Care Medicine, 1999
• Augmentation therapy for severe alpha 1-antitrypsin deficiency: is the jury still out on a trial?
  Thorax, 1998
• Effects of an Immunostimulating Agent on Acute Exacerbations and Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease
  American Journal of Respiratory and Critical Care Medicine, 1997
• Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group
  European Respiratory Journal, 1997
• Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ)
  Thorax, 1997
• Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group.
  American Journal of Respiratory and Critical Care Medicine, 1996
• Quantum proteolysis resulting from release of single granules by human neutrophils: a novel, nonoxidative mechanism of extracellular proteolytic activity.
  The Journal of Immunology, 1996
• Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease.
  Thorax, 1996
• Nonisotropic Enzyme-Inhibitor Interactions: A Novel Nonoxidative Mechanism for Quantum Proteolysis by Human Neutrophils
  Biochemistry, 1995
• Preliminary Evidence That Augmentation Therapy Diminishes Degradation of Cross-Linked Elastin in Alpha-1-Antitrypsin-Deficient Humans
  Respiration, 1995